Načítá se...
Multifunctional receptor-directed drugs for disorders of the central nervous system
The marked decline in FDA-approved new drug candidates in recent years suggests the possibility that the “low-hanging fruit” has been almost entirely harvested. This might be particularly applicable to drugs acting on the central nervous system. Fortunately, there are several examples extant for the...
Uloženo v:
| Vydáno v: | Neurotherapeutics |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer-Verlag
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084252/ https://ncbi.nlm.nih.gov/pubmed/19110195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.10.031 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|